AD

Apoorva Dixit

Active Director Director DIN 10631923
DIN 10631923 First appointment Jun 2024 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Apoorva Dixit

Data last updated:

Apoorva Dixit is a Director at Kepler Medical Devices Private Limited (since 2024). The company operates in Healthcare.

DIN 10631923
Primary Designation Director
Industry Healthcare
First Appointment 07 Jun 2024
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director07 Jun 20242021Active

Board colleagues of Apoorva Dixit

Directorship timeline

Open interactive timeline →
Kepler Medical Devices Private Limited
Premium access

Shareholding and investment profile for Apoorva Dixit

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Apoorva Dixit

Apoorva Dixit currently holds 1 directorship: Kepler Medical Devices Private Limited (Director, since 07 Jun 2024).

Apoorva Dixit was first appointed on 07 Jun 2024 as Director at Kepler Medical Devices Private Limited.

The current boards of Apoorva Dixit's companies include Nitesh Kumar Shukla (Kepler Medical Devices Private Limited), Shiwendra Kumar Shukla (Kepler Medical Devices Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available